These nanoparticles exploit the high ROS gradient in the glioma microenvironment to trigger the selective binding of Au(I) to overexpressed TrxR, activating HMOX1-regulated noncanonical ferroptosis in glioma cells and leading to tumor suppression (Zhang Xiaoqian et al., 2023). This evidence concerns the gene HMOX1 and glioma.